Home Elucid Bioimaging Inc.

Elucid Bioimaging Inc.

Elucid Bio: Study Demonstrates that AI Technology is Better Predictor of Stroke than Traditional Methods

The study, led by Dr. Brajesh Lal, Director of both the University of Maryland’s Center for Vascular Diagnostics and the NIH Vascular Imaging Core Facility, with participation by the Cleveland Clinic, Weill-Cornell, and Case Western, sought to improve prediction of Major Adverse Neurological Events (MANE; stroke, transient ischemic attack, and amaurosis fugax) by applying AI to traditional carotid imaging using the Elucid Bio vascuCAP software.